Literature DB >> 33563308

Genetic markers of osteoarthritis: early diagnosis in susceptible Pakistani population.

Yasmin Badshah1, Maria Shabbir2, Hunza Hayat2, Zoha Fatima2, Asad Burki3, Sidra Khan4, Shafiq Ur Rehman5.   

Abstract

BACKGROUND AND AIM: Osteoarthritis (OA) is a multiple factorial disease with unidentified specific markers. The alternate method such as biochemical and genetic markers for the diagnosis of osteoarthritis is an undeniable need of the current era. In the present study, we aimed to investigate the association of interleukin-6 (IL-6)(IL-6-174G/C), transforming growth factor-β1 (TGF-beta1-29C/T), and calmodulin 1 gene-16C/T (CALM1-16C/T) polymorphism in clinically definite Pakistani OA patients and matching controls.
METHODS: The study design was based on biochemical analysis of OA via serum hyaluronic acid (HA) enzyme-linked immunosorbent assay (ELISA) test and genetic analysis based on amplification refractory mutation system (ARMS) PCR. Statistical evaluations of allele probabilities were carried through chi-squared test. This study includes 295 subjects including 100 OA patients, 105 OA susceptible, and 90 controls.
RESULTS: HA levels obtained were distinct for all the populations: patients with a mean value of ± 5.15, susceptible with mean value of ± 2.27, and control with mean value of ± 0.50. The prevalent genotypes in OA were GG genotype for IL-6-174G/C, CT genotypes for TGF β1-29C/T, and TT genotype for CALM1-16C/T polymorphism. A significant P value of 0.0152 is obtained as a result of the comparison among the patients and controls on the number of individuals possessing the disease-associated genotypes.
CONCLUSIONS: The positive association of GG genotype for IL-6-174G/C, TT genotype for CALM1-16C/T polymorphism in OA while high prevalence of CT TGF β1-29 C/T genotypes in susceptible population in our study group implies these polymorphisms can serve as susceptible marker to OA and genetic factors for screening OA patients in Pakistan. There might be other factors that may influence disease susceptibility. However, further investigations on larger population are required to determine the consequences of genetic variations for prediagnosis of OA.

Entities:  

Keywords:  ARMS PCR; Genotype; Hyaluronic acid; Polymorphism

Mesh:

Substances:

Year:  2021        PMID: 33563308      PMCID: PMC7871631          DOI: 10.1186/s13018-021-02230-x

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


  36 in total

Review 1.  Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria.

Authors:  W E van Spil; J DeGroot; W F Lems; J C M Oostveen; F P J G Lafeber
Journal:  Osteoarthritis Cartilage       Date:  2010-02-06       Impact factor: 6.576

Review 2.  Osteoarthritis.

Authors:  David J Hunter; David T Felson
Journal:  BMJ       Date:  2006-03-18

3.  Knee osteoarthritis, knee joint pain and aging in relation to increasing serum hyaluronan level in the Japanese population.

Authors:  R Inoue; Y Ishibashi; E Tsuda; Y Yamamoto; M Matsuzaka; I Takahashi; K Danjo; T Umeda; S Nakaji; S Toh
Journal:  Osteoarthritis Cartilage       Date:  2010-10-31       Impact factor: 6.576

4.  Differential gene expression of cultured human osteoblasts.

Authors:  I Shur; F Lokiec; I Bleiberg; D Benayahu
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

5.  Association of interleukin-6 and transforming growth factor-β1 gene polymorphisms with developmental hip dysplasia and severe adult hip osteoarthritis: a preliminary study.

Authors:  Robert Kolundžić; Vladimir Trkulja; Michele Mikolaučić; Mirna Jovanić Kolundžić; Sandra Kraljević Pavelić; Krešimir Pavelić
Journal:  Cytokine       Date:  2011-02-25       Impact factor: 3.861

6.  The CALM1 core promoter polymorphism is not associated with hip osteoarthritis in a United Kingdom Caucasian population.

Authors:  J Loughlin; J S Sinsheimer; A Carr; K Chapman
Journal:  Osteoarthritis Cartilage       Date:  2005-12-13       Impact factor: 6.576

7.  A functional single nucleotide polymorphism in the core promoter region of CALM1 is associated with hip osteoarthritis in Japanese.

Authors:  Hideyuki Mototani; Akihiko Mabuchi; Susumu Saito; Mikihiro Fujioka; Aritoshi Iida; Yoshio Takatori; Akihiro Kotani; Toshikazu Kubo; Kozo Nakamura; Akihiro Sekine; Yoshinori Murakami; Tatsuhiko Tsunoda; Kohei Notoya; Yusuke Nakamura; Shiro Ikegawa
Journal:  Hum Mol Genet       Date:  2005-03-03       Impact factor: 6.150

Review 8.  2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Authors:  Jasvinder A Singh; Kenneth G Saag; S Louis Bridges; Elie A Akl; Raveendhara R Bannuru; Matthew C Sullivan; Elizaveta Vaysbrot; Christine McNaughton; Mikala Osani; Robert H Shmerling; Jeffrey R Curtis; Daniel E Furst; Deborah Parks; Arthur Kavanaugh; James O'Dell; Charles King; Amye Leong; Eric L Matteson; John T Schousboe; Barbara Drevlow; Seth Ginsberg; James Grober; E William St Clair; Elizabeth Tindall; Amy S Miller; Timothy McAlindon
Journal:  Arthritis Rheumatol       Date:  2015-11-06       Impact factor: 10.995

9.  Transforming growth factor beta-1 (TGFB1) and peak bone mass: association between intragenic polymorphisms and quantitative ultrasound of the heel.

Authors:  Peter Tzakas; Betty Y L Wong; Alexander G Logan; Laurence A Rubin; David E C Cole
Journal:  BMC Musculoskelet Disord       Date:  2005-06-14       Impact factor: 2.362

10.  Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis.

Authors:  Olli-Pekka Kämäräinen; Svetlana Solovieva; Tapio Vehmas; Katariina Luoma; Hilkka Riihimäki; Leena Ala-Kokko; Minna Männikkö; Päivi Leino-Arjas
Journal:  Arthritis Res Ther       Date:  2008-02-08       Impact factor: 5.156

View more
  2 in total

1.  Association of IL-6 and TGF-β Gene Polymorphisms with the Risk of Thoracolumbar Osteoporotic Vertebral Compression Fractures.

Authors:  Yi Xiong; Ye He; Yan Peng; Yun Geng
Journal:  Pharmgenomics Pers Med       Date:  2022-04-19

2.  Identification and validation of key long non-coding RNAs in resveratrol protect against IL-1β-treated chondrocytes via integrated bioinformatic analysis.

Authors:  Hong Yi; Wei Zhang; Sheng-Yu Cui; Jian-Bo Fan; Xin-Hui Zhu; Wei Liu
Journal:  J Orthop Surg Res       Date:  2021-07-02       Impact factor: 2.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.